Compare MPLX LP (MPLX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Tempus AI — how do they compare? MPLX LP trades at $60.05 (market cap $61.06B), while Tempus AI trades at $60.35 (market cap $11.13B). The key difference: MPLX LP is far larger — about 5.5× Tempus AI's market cap, and MPLX LP pays a 7.15% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| MPLX | TEM | |
|---|---|---|
Market Cap | $61.06B | $11.13B |
Sector | Technology | Broad Market / Factor |
52-Week High | $60.51 | $103.25 |
52-Week Low | $47.80 | $41.55 |
Enterprise Value | $86.17B | $11.75B |
Dividend Yield | 7.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $59.83, up 0.27% today, with a bullish technical signal from moving averages and a consensus analyst price target of $64.00. The company reported strong 2025 results with $11.47B revenue and $4.91B net income, though recent quarterly EPS results have missed expectations. A $1.08 dividend is scheduled for August 2026, supporting its income appeal.
The outlook remains positive given analyst buy ratings and growth projects, but risks include rising leverage near 4x and sensitivity to energy market volatility. Earnings consistency in upcoming quarters is critical to sustaining the current valuation and distribution growth trajectory.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company reported a net loss of $245.03M in 2025 despite revenue of $1.27B, but recent quarterly EPS beats and FDA clearance for an AI-enabled ECG product (Business Wire, 2026-08-24) highlight growth potential in precision medicine. Analyst consensus is strongly bullish with a $69.20 price target.
Outlook: TEM's AI-driven healthcare platform positions it for long-term growth amid industry shifts toward personalized medicine, though persistent losses and high P/B of 25.01 pose valuation risks. Near-term catalysts include continued execution on recent contracts and pipeline developments, but investors face volatility from cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
